Further study of the management of cervical adenocarcinoma in situ

Gynecologic Oncology

Volumn 86, Issue 3, 2002, Pages 361-364

  Kennedy, Alexander W ^a   Biscotti, Charles V ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; AGE; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER THERAPY; CONTROLLED STUDY; EXCISION; HUMAN; HYSTERECTOMY; ORGANIZATION; PAPANICOLAOU TEST; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CONIZATION;

EID: 0036445660     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6771     Document Type: Article

References (11)

1. Widdrich T, Kennedy AW, Myers TM, Hart WR, Wirth S. Adenocarcinoma in situ of the uterine cervix: Management and outcome. Gynecol Oncol 1996;61:304-8.
2. Kennedy AW, El Tabbakh GH, Biscotti CV, Wirth S. Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ. Gynecol Oncol 1995;58: 274-7.
3. Madeleine MM, Daling JR, Schwartz SM, Shera K, McKnight B, Carter JJ, Wipf GC, Critchlow CW, McDougall JK, Porter P, Galloway DA. Human papilloma virus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiol Biomark Prev 2001;10:171-7.
4. Goldstein NS, Mani A. The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ. Anat Pathol 1998;109:727-32.
5. McHale MT, Le TD, Burger RA, Gu M, Rutgers JL, Monk BJ. Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix. Obstet Gynecol 2001,98:726-31.
6. Wolf JK, Levenback C, Malpica A, Morris M, Burke T, Mitchell MF. Adenocarcinoma in situ of the cervix: Significance of cone biopsy margins. Gynecol Oncol 1996;88:82-6.
7. Denchy TR, Gregori CA, Breen JL. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix. Obstet Gynecol 1997;90:1-6.
8. Azodi M, Chambers SK, Rutherford TJ, Kohorn EI, Schwartz PE, Chambers JT. Adenocarcinoma in situ of the cervix: Management and outcome. Gynecol Oncol 1999;73:348-53.
9. Muntz HG, Bell DA, Lage JM, Goff BA, Feldman S, Rice LW. Adenocarcinoma in situ of the uterine cervix. Obstet Gynecol 1992;80:935-9.
10. Poynor EA, Barakat RR, Hoskins WJ. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix. Gynecol Oncol 1995;57:158-64.
11. Maini M, Lavie O, Comerci G, Cross PA, Bolger B, Lopes A, Monaghan JM. The management and follow-up of patients with high-grade cervical glandular intra-epithelial neoplasia. Int J Gynecol Cancer 1998;8:287-91.